While glutaminase inhibitors have shown limited success in tumor inhibition, the aminotransferase inhibitor JHU-083 has been notably effective in reducing tumor growth in mouse models, highlighting the vital role of aminotransferases in RCC progression [109]. Here, GLS is linked to neoplasm.